Ratings and dated fundamentals
Exact eligible report scores in ranking order. Ratings summarize dated reports, not future returns; report and market dates remain in the table. Showing the first 10 of 301 recorded values; the complete table remains available below.
See the complete ratings and dated fundamentals
Scroll sideways to compare all columns. Select a heading to sort.
| 1 | ResMed Inc. | RMD | 4.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $235.3 | $33,096,608,806.3 | 20.77 | 5.56 |
| 2 | Ametek, Inc. | AME | 4 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $228.67 | $52,438,146,602.66 | 32.15 | 4.48 |
| 3 | Idexx Laboratories Inc | IDXX | 4 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $676.04 | $53,262,666,590.6 | 45.05 | 28.5 |
| 4 | iRadimed Corporation | IRMD | 4 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $86.31 | $1,103,745,485.43 | 46.02 | 10.37 |
| 5 | Intuitive Surgical Inc. | ISRG | 4 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $452.8 | $156,960,275,510.4 | 53.08 | 9.74 |
| 6 | UFP Technologies Inc | UFPT | 4 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $303.47 | $2,350,977,841.42 | 30.72 | 4.84 |
| 7 | United Therapeutics Corp | UTHR | 4 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $562.02 | $23,935,715,786.52 | 19.45 | 3.81 |
| 8 | ZOETIS INC. | ZTS | 4 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $79.4 | $32,261,502,071.8 | 12.98 | 9.77 |
| 9 | Agilent Technologies Inc. | A | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $174.76 | $49,269,886,525.04 | 34.22 | 6.69 |
| 10 | Alcon Inc. Ordinary Shares | ALC | 3.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $74.94 | $36,225,996,000 | 36.97 | 1.64 |
| 11 | Align Technology Inc | ALGN | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $166 | $11,700,850,798 | 23.79 | 2.72 |
| 12 | AptarGroup, Inc. | ATR | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $142.5 | $9,032,929,650 | 33.81 | Not reported |
| 13 | Becton, Dickinson and Co. | BDX | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $211.88 | $57,713,315,184 | 61.33 | Not reported |
| 14 | Berkshire Hathaway Inc. | BRK-A | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $856,612 | $1,222,245,324,463.29 | 14.25 | 1.63 |
| 15 | BERKSHIRE HATHAWAY Class B | BRK-B | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $570.89 | $1,222,245,324,463.29 | 14.25 | 1.63 |
| 16 | Boston Scientific Corp. | BSX | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $42.75 | $61,964,980,240.5 | 17.73 | Not reported |
| 17 | BWX Technologies, Inc. | BWXT | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $119.52 | $10,951,043,545.44 | 29.22 | 7.72 |
| 18 | Cardinal Health, Inc. | CAH | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $271.72 | $62,804,451,896.6 | 34.55 | Not reported |
| 19 | CONMED Corporation | CNMD | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $51.5 | $1,534,871,134.5 | 20.9 | 1.45 |
| 20 | DexCom, Inc. | DXCM | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $79.41 | $29,616,032,716.02 | 29.88 | 11.68 |
| 21 | Ecolab, Inc. | ECL | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $300.68 | $84,331,053,593.8 | 40.49 | 8.07 |
| 22 | Electromed, Inc. | ELMD | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $27.17 | $227,308,648.71 | 20.11 | 4.21 |
| 23 | Edwards Lifesciences Corp | EW | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $102.14 | $58,730,500,000 | 57.51 | 5.36 |
| 24 | GE HealthCare Technologies Inc. Common Stock | GEHC | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $82.38 | $37,247,114,517.78 | 17.3 | 3.14 |
| 25 | GLOBUS MEDICAL INC | GMED | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $71.05 | $9,539,308,989.7 | 17.11 | 1.99 |
| 26 | Gentex Corp | GNTX | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $19.88 | $4,081,891,138.08 | 10.29 | 1.64 |
| 27 | Haemonetics Corporation | HAE | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $119.93 | $5,461,313,694.23 | 52.56 | Not reported |
| 28 | Halozyme Therapeutics, Inc. | HALO | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $103.63 | $11,814,856,300 | 24.34 | Not reported |
| 29 | IDEX Corporation | IEX | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $226.99 | $16,673,051,298.99 | 31.12 | 4.15 |
| 30 | InMode Ltd. Ordinary Shares | INMD | 3.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $13.33 | $767,063,812.76 | 8.17 | 1.12 |
| 31 | Johnson & Johnson | JNJ | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $276.22 | $664,947,241,674.52 | 41.31 | 8.16 |
| 32 | LivaNova PLC Ordinary Shares | LIVN | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $89.99 | $4,957,261,941.91 | 25.28 | 3.61 |
| 33 | LeMaitre Vascular, Inc. | LMAT | 3.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $80.89 | $1,850,833,655.19 | 29.22 | 4.28 |
| 34 | McKesson Corporation | MCK | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1,060.84 | $122,481,047,437.76 | 26.06 | Not reported |
| 35 | Medtronic plc | MDT | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $101.8 | $130,216,237,202 | 24.89 | 2.56 |
| 36 | MiMedx Group, Inc | MDXG | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $3.31 | $483,013,706.21 | Not reported | 2.29 |
| 37 | Merit Medical Systems Inc | MMSI | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $87.23 | $5,226,389,288.12 | 32.64 | 3 |
| 38 | Nordson Corp | NDSN | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $309.86 | $17,259,005,548.76 | 31.09 | Not reported |
| 39 | Novo-Nordisk A/S | NVO | 3.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $40.31 | $179,137,640,000 | 11.55 | 5.88 |
| 40 | OSI Systems Inc | OSIS | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $196.36 | $3,088,380,712.16 | 19.46 | 3.95 |
| 41 | Insulet Corporation | PODD | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $146.51 | $10,163,551,509.93 | 23.7 | 6.44 |
| 42 | Roper Technologies, Inc. Common Stock | ROP | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $476.6 | $47,200,762,061.4 | 18.22 | 2.46 |
| 43 | Stryker Corporation | SYK | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $325.87 | $124,055,777,473.48 | 34.24 | 5.29 |
| 44 | Tactile Systems Technology, Inc. | TCMD | 3.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $26.03 | $583,107,739.19 | 24.48 | 2.57 |
| 45 | TE Connectivity plc | TEL | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $207.01 | $59,932,133,328.28 | 19.87 | 4.47 |
| 46 | Thermo Fisher Scientific, Inc. | TMO | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $694.76 | $257,419,604,451.68 | 36.42 | Not reported |
| 47 | Veracyte, Inc. | VCYT | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $24.16 | $1,949,602,796.8 | 15.37 | 1.36 |
| 48 | Waters Corp | WAT | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $457.6 | $44,958,335,593.6 | 270.61 | 2.96 |
| 49 | West Pharmaceutical Services, Inc. | WST | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $399.81 | $27,851,178,803.16 | 43.59 | 9.38 |
| 50 | Zimmer Biomet Holdings, Inc. | ZBH | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $105.59 | $19,983,318,033.92 | 26.04 | 1.57 |
| 51 | ABBVIE INC. | ABBV | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $291.31 | $514,924,306,100.86 | 49.79 | Not reported |
| 52 | Abbott Laboratories | ABT | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $109.93 | $190,392,340,197.93 | 40.5 | Not reported |
| 53 | CareDx, Inc. | CDNA | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $78.56 | $4,127,761,268.16 | 32.09 | 8.83 |
| 54 | Church & Dwight Co., Inc. | CHD | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $109.33 | $25,805,384,245.16 | 33.31 | 5.75 |
| 55 | Coherent Corp. | COHR | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $192.81 | $37,975,600,969.89 | 39.42 | 3.26 |
| 56 | The Cooper Companies, Inc. Common Stock | COO | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $62.36 | $11,858,084,133.84 | 20.79 | 1.42 |
| 57 | Castle Biosciences, Inc. Common Stock | CSTL | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $32.52 | $1,002,210,823.32 | Not reported | 2.09 |
| 58 | Danaher Corporation | DHR | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $230.25 | $161,987,970,153.75 | 37.4 | Not reported |
| 59 | Flex Ltd. Ordinary Shares | FLEX | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $69.78 | $25,779,127,599.1 | 24.86 | 4.44 |
| 60 | Haleon plc American Depositary Shares (Each representing two Ordinary Shares) | HLN | 3 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $9.14 | $40,912,256,171.36 | 18.47 | 1.85 |
| 61 | Hinge Health, Inc. | HNGE | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $115.76 | $9,341,185,711.92 | 85.64 | 27.13 |
| 62 | Henry Schein Inc | HSIC | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $86.05 | $9,511,841,539.1 | 22.59 | 2.01 |
| 63 | InfuSystem Holdings, Inc. | INFU | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $13.69 | $272,666,207.89 | 31.92 | 4.61 |
| 64 | Inspire Medical Systems, Inc. | INSP | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $63.98 | $1,853,252,293.62 | 18.4 | 2.24 |
| 65 | Integer Holdings Corporation | ITGR | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $126.56 | $4,302,702,970.72 | 41.49 | 2.49 |
| 66 | Jabil Inc. | JBL | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $239.09 | $24,620,166,032.3 | 23.63 | 15.23 |
| 67 | Kimball Electronics, Inc. | KE | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $19.26 | $461,782,401.66 | 22.51 | 0.79 |
| 68 | Lantheus Holdings, Inc | LNTH | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $100.61 | $6,580,036,161.93 | 24.38 | 4.85 |
| 69 | Mesa Laboratories Inc | MLAB | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $128.25 | $717,670,199.25 | 149.51 | 3.8 |
| 70 | Mannkind Corporation | MNKD | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $3.9 | $1,254,396,460.2 | Not reported | Not reported |
| 71 | Materialise NV | MTLS | 3 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $6.75 | $398,703,505.5 | 45.72 | Not reported |
| 72 | Novanta Inc. Common Stock | NOVT | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $135.15 | $5,111,071,615.5 | 82.75 | 3.16 |
| 73 | Pro-Dex Inc New | PDEX | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $63.16 | $202,096,063.16 | 16.8 | 4.1 |
| 74 | Penumbra, Inc. | PEN | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $319.21 | $12,581,465,835.85 | 80.13 | 7.95 |
| 75 | RadNet, Inc. Common Stock | RDNT | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $76 | $5,980,991,532 | Not reported | 4.29 |
| 76 | Revvity, Inc. | RVTY | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $155.11 | $17,308,166,659.11 | 72.86 | 2.39 |
| 77 | Smith & Nephew plc | SNN | 3 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $31.15 | $13,670,564,460.88 | 21.87 | 2.58 |
| 78 | Stevanato Group S.p.A. | STVN | 3 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $13.57 | $3,706,356,011.19 | 23.45 | 2.13 |
| 79 | Bio-Techne Corp. | TECH | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $72.78 | $11,430,503,947.92 | 62.85 | Not reported |
| 80 | Gentherm Inc | THRM | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $29.47 | $1,547,307,968.64 | 171.26 | 2.15 |
| 81 | Telix Pharmaceuticals Limited American Depositary Shares | TLX | 3 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $9.63 | $3,262,422,981.87 | Not reported | 7.85 |
| 82 | TransMedics Group, Inc. Common Stock | TMDX | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $88.24 | $3,064,917,835.92 | 21.22 | 5.57 |
| 83 | Utah Medical Products Inc | UTMD | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $72.23 | $229,967,174.14 | 21.93 | 1.88 |
| 84 | Vericel Corporation | VCEL | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $54.62 | $2,787,246,037.4 | 83.68 | 7.26 |
| 85 | Viemed Healthcare, Inc. Common Shares | VMD | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $9.13 | $345,963,948.22 | 22.14 | 2.28 |
| 86 | Adaptive Biotechnologies Corporation Common Stock | ADPT | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $27.98 | $4,529,309,898.12 | Not reported | 24.63 |
| 87 | AdaptHealth Corp. Common Stock | AHCO | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $7.33 | $1,000,730,800.84 | Not reported | 0.81 |
| 88 | Artivion, Inc. | AORT | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $20.21 | $986,041,292.12 | Not reported | 2.21 |
| 89 | AtriCure, Inc. | ATRC | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $58.54 | $2,980,990,446.82 | 200.29 | 5.59 |
| 90 | Aveanna Healthcare Holdings Inc. Common Stock | AVAH | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $13.25 | $2,891,410,972 | 10.52 | 10.04 |
| 91 | Axogen, Inc. Common Stock | AXGN | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $50.02 | $2,987,730,364.3 | Not reported | 6.02 |
| 92 | Baird Medical Investment Holdings Ltd Ordinary Share | BDMD | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $0.09 | $2,825,894.72 | Not reported | 0.09 |
| 93 | Bio-Rad Laboratories, Inc.Class A | BIO | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $381.57 | $10,202,485,434.75 | 9.97 | 1.34 |
| 94 | Bausch + Lomb Corporation | BLCO | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $19.99 | $7,146,372,506.26 | Not reported | 1.1 |
| 95 | Bruker Corporation | BRKR | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $61.31 | $9,363,376,316.95 | Not reported | Not reported |
| 96 | Bioventus Inc. Class A Common Stock | BVS | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $10.61 | $892,214,846.8 | 15.57 | 3.06 |
| 97 | Caris Life Sciences, Inc. Common Stock | CAI | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $25.23 | $7,235,573,035.92 | 75.32 | 11.31 |
| 98 | Carlsmed, Inc. Common Stock | CARL | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $14.52 | $396,435,828.36 | Not reported | 4.71 |
| 99 | Cytek Biosciences, Inc. Common Stock | CTKB | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $5.83 | $762,470,527.61 | Not reported | 2.37 |
| 100 | Delcath Systems Inc | DCTH | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $14.93 | $518,053,009.35 | 973.78 | 4.28 |
| 101 | DuPont de Nemours, Inc. Common Stock | DD | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $146.52 | $19,418,638,163.76 | 64.51 | 1.42 |
| 102 | Embecta Corp. Common Stock | EMBC | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $6.19 | $350,722,917.81 | 4.01 | Not reported |
| 103 | National Vision Holdings, Inc. Common Stock | EYE | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $17.9 | $1,415,340,702.7 | 28.15 | 1.58 |
| 104 | Fresenius Medical Care AG | FMS | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $23.4 | $11,477,216,368.8 | 8.52 | 0.68 |
| 105 | Glaukos Corporation | GKOS | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $224.41 | $13,284,369,596.7 | Not reported | 18.52 |
| 106 | Integra LifeSciences Holdings | IART | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $13.42 | $1,044,089,097.92 | 80.23 | 0.98 |
| 107 | ICU Medical Inc | ICUI | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $172.11 | $4,304,488,138.89 | 71.35 | Not reported |
| 108 | Illumina Inc | ILMN | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $213.13 | $32,225,256,000 | 36.01 | Not reported |
| 109 | IPG Photonics Corporation | IPGP | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $65.31 | $2,776,206,623.4 | Not reported | 1.29 |
| 110 | iRhythm Holdings, Inc. Common Stock | IRTC | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $90.22 | $3,033,029,132.12 | Not reported | 17.13 |
| 111 | Medline Inc. Class A common stock | MDLN | 2.5 | 2026-10-14 | 2026 IPO | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $39.64 | $34,778,202,281.52 | Not reported | 1.79 |
| 112 | Nephros Inc. | NEPH | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.79 | $30,327,311.16 | Not reported | 2.42 |
| 113 | Anbio Biotechnology Class A Ordinary Shares | NNNN | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $3.89 | $170,736,768 | 26.66 | 5.66 |
| 114 | Neuropace, Inc. Common Stock | NPCE | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $12.5 | $429,053,425 | Not reported | 36.11 |
| 115 | Natera, Inc. Common Stock | NTRA | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $310.67 | $45,048,554,539.07 | Not reported | 24.1 |
| 116 | Envista Holdings Corporation Common stock, $0.01 par value per share | NVST | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $25.17 | $4,035,882,089.46 | 6.37 | Not reported |
| 117 | Organon & Co. | OGN | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $13.87 | $3,642,561,370.08 | 17.1 | 3.05 |
| 118 | Organogenesis Holdings Inc. Class A Common Stock | ORGO | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.81 | $105,554,758.7 | Not reported | 0.4 |
| 119 | Pacira BioSciences, Inc. Common Stock | PCRX | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $36.43 | $1,460,648,463.8 | 38.72 | 2.05 |
| 120 | KONINKLIJKE PHILIPS N.V. | PHG | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $30.35 | $29,670,584,900 | 29.27 | 2.3 |
| 121 | PROCEPT BioRobotics Corporation Common Stock | PRCT | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $20.62 | $1,186,394,815.02 | Not reported | 3.61 |
| 122 | QIAGEN N.V. | QGEN | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $50.33 | $10,392,969,901.93 | 24.46 | 2.75 |
| 123 | Rockwell Medical, Inc. (DE) Common Stock | RMTI | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $7.73 | $31,155,494.45 | Not reported | 0.89 |
| 124 | RxSight, Inc. Common Stock | RXST | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $4.54 | $190,358,667.88 | Not reported | 0.75 |
| 125 | SI-BONE, Inc. Common Stock | SIBN | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $24.24 | $1,093,541,228.88 | Not reported | 5.92 |
| 126 | SANUWAVE Health, Inc. Common Stock | SNWV | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.19 | $18,839,056.71 | 1.32 | 6.76 |
| 127 | Solventum Corporation | SOLV | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $90.38 | $15,341,041,097.3 | 98.34 | 3.19 |
| 128 | Sensus Healthcare, Inc | SRTS | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.86 | $47,081,488.74 | Not reported | 1.28 |
| 129 | Staar Surgical Co | STAA | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $25.21 | $1,265,587,856.99 | 2,387.9 | 3.36 |
| 130 | Teleflex Incorporated | TFX | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $150.87 | $5,983,694,447.07 | 19.64 | 1.71 |
| 131 | Varex Imaging Corporation Common Stock | VREX | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $18.44 | $776,324,000 | 35.13 | 1.52 |
| 132 | Warby Parker Inc. | WRBY | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $25.48 | $3,149,533,215.92 | 421.57 | 7.81 |
| 133 | Xtant Medical Holdings, Inc. | XTNT | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.29 | $40,599,335.62 | Not reported | 1.01 |
| 134 | JIN MEDICAL INTERNATIONAL LTD. Class A Ordinary Shares | ZJYL | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $3.36 | $247,509,118.08 | 207.76 | 8.37 |
| 135 | Zai Lab Limited American Depositary Shares | ZLAB | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $25.48 | $2,864,773,806.44 | Not reported | 5.09 |
| 136 | AETHLON MEDICAL INC | AEMD | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $5.47 | $3,889,913.92 | Not reported | Not reported |
| 137 | Akso Health Group ADS | AHG | 2 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $1.35 | $1,156,550,638.5 | Not reported | 6.39 |
| 138 | American Shared Hospital Services | AMS | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.16 | $7,714,000 | Not reported | 0.3 |
| 139 | AngioDynamics, Inc. | ANGO | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $11.73 | $493,298,698.5 | Not reported | 3.01 |
| 140 | Anika Therapeutics Inc | ANIK | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $14.55 | $194,901,804.15 | Not reported | Not reported |
| 141 | Apyx Medical Corporation Common Stock | APYX | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.93 | $123,423,387.39 | Not reported | 12.3 |
| 142 | Accuray Incorporated | ARAY | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.11 | $13,138,323.77 | Not reported | 0.32 |
| 143 | Alphatec Holdings, Inc. | ATEC | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $7.44 | $1,154,240,290.56 | Not reported | Not reported |
| 144 | Baxter International Inc. | BAX | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $25.79 | $13,342,409,768.52 | Not reported | 2.06 |
| 145 | Beta Bionics, Inc. Common Stock | BBNX | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $15.7 | $853,562,951.9 | Not reported | 2.13 |
| 146 | Butterfly Network, Inc. | BFLY | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $6.37 | $1,696,236,615.71 | Not reported | 9.2 |
| 147 | Bausch Health Companies Inc | BHC | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $8.18 | $3,061,501,736.88 | Not reported | Not reported |
| 148 | CeriBell, Inc. Common Stock | CBLL | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $26.59 | $1,032,622,915.9 | Not reported | 8.79 |
| 149 | Cerus Corp | CERS | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.02 | $407,947,451.68 | Not reported | 5.34 |
| 150 | CVRx, Inc. Common Stock | CVRX | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.87 | $24,744,936.01 | Not reported | 1.79 |
| 151 | Journey Medical Corporation Common Stock | DERM | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $4.47 | $126,163,045.65 | Not reported | 3.93 |
| 152 | DarioHealth Corp. Common Stock | DRIO | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.38 | $23,273,767.38 | Not reported | 0.42 |
| 153 | electroCore, Inc. Common Stock | ECOR | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $7.25 | $66,888,543.5 | Not reported | Not reported |
| 154 | Enovis Corporation | ENOV | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $27.16 | $1,566,990,930.96 | Not reported | 1.05 |
| 155 | Guardant Health, Inc. Common Stock | GH | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $150.87 | $20,410,595,048.25 | Not reported | Not reported |
| 156 | GRAIL, Inc. Common Stock | GRAL | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $121.44 | $5,460,206,046.24 | Not reported | 2.23 |
| 157 | Helen Of Troy Ltd | HELE | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $37.43 | $875,511,468.05 | Not reported | 1.03 |
| 158 | Heartflow, Inc. Common Stock | HTFL | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $52.4 | $4,556,370,054.8 | Not reported | 16.29 |
| 159 | Inogen Inc | INGN | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $6.03 | $160,026,172.11 | Not reported | 0.92 |
| 160 | OrthoPediatrics Corp. Common Stock | KIDS | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $31.76 | $829,268,717.76 | Not reported | 2.44 |
| 161 | Kestra Medical Technologies, Ltd. Common Stock | KMTS | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $28.8 | $1,715,379,696 | Not reported | 7.71 |
| 162 | KORU Medical Systems, Inc. Common Stock (DE) | KRMD | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $3.09 | $142,671,177.18 | Not reported | 7.9 |
| 163 | Pulmonx Corporation Common Stock | LUNG | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.56 | $111,489,702.4 | Not reported | 3.26 |
| 164 | Spectral AI, Inc. Class A Common Stock | MDAI | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.49 | $47,955,542.72 | Not reported | Not reported |
| 165 | Myriad Genetics Inc | MYGN | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $5.92 | $566,245,898.4 | Not reported | 1.86 |
| 166 | Myomo Inc. | MYO | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.21 | $47,925,503.34 | Not reported | 8.22 |
| 167 | Natural Health Trends Corp. | NHTC | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.77 | $6,537,570.38 | Not reported | 0.44 |
| 168 | NN Inc | NNBR | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.75 | $226,789,750 | Not reported | 1.63 |
| 169 | Nano Dimension Ltd. American Depositary Shares | NNDM | 2 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $1.32 | $261,665,673.72 | Not reported | 0.6 |
| 170 | InspireMD, Inc. | NSPR | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.7 | $32,356,426.13 | Not reported | 1.03 |
| 171 | Nortech Systems Inc | NSYS | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $11.2 | $31,961,893.82 | 30.94 | 0.9 |
| 172 | NovoCure Limited Ordinary Shares | NVCR | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $13.28 | $1,552,643,935.52 | Not reported | 4.43 |
| 173 | NexGel, Inc Common Stock | NXGL | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $3.6 | $1,754,578.8 | Not reported | 0.32 |
| 174 | Orthofix Medical Inc. Common Stock (DE) | OFIX | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $7.87 | $320,565,624.96 | Not reported | 0.75 |
| 175 | Opko Health Inc. | OPK | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.73 | $1,284,536,205.21 | Not reported | 1.15 |
| 176 | OraSure Technologies Inc | OSUR | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $3.44 | $237,252,076.88 | Not reported | 0.75 |
| 177 | Owlet, Inc. | OWLT | 2 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $4.17 | $121,854,393.09 | Not reported | 3.14 |
| 178 | Pulse Biosciences, Inc Common Stock (DE) | PLSE | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $53.29 | $3,919,422,159.96 | Not reported | 21.35 |
| 179 | Precision Optics Corporation, Inc. Common Stock | POCI | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $4.89 | $53,627,326.34 | Not reported | 2.64 |
| 180 | Profound Medical Corp. Common Stock | PROF | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $7.21 | $264,079,545.24 | Not reported | 6.21 |
| 181 | Personalis, Inc. Common Stock | PSNL | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $15.79 | $1,711,696,223.06 | Not reported | 8.05 |
| 182 | QuidelOrtho Corporation Common Stock | QDEL | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $10.7 | $734,154,691.6 | Not reported | 0.41 |
| 183 | Rafael Holdings, Inc. Class B Common Stock | RFL | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.04 | $54,271,982.96 | Not reported | 0.75 |
| 184 | RenovoRx, Inc. Common Stock | RNXT | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.13 | $54,523,168.96 | Not reported | 5.87 |
| 185 | Sight Sciences, Inc. Common Stock | SGHT | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $10.08 | $560,236,088.16 | Not reported | 11.4 |
| 186 | SkinHealth Systems Inc. Class A Common Stock | SKIN | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $15.71 | $102,782,172.28 | Not reported | 1.84 |
| 187 | Sanara MedTech Inc. Common Stock | SMTI | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $31.55 | $289,882,504.25 | Not reported | 36.53 |
| 188 | Sonoma Pharmaceuticals, Inc. Common Stock | SNOA | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.11 | $5,315,151.75 | Not reported | 0.81 |
| 189 | SOPHiA GENETICS SA Ordinary Shares | SOPH | 2 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $7.14 | $611,600,411.94 | Not reported | 12.97 |
| 190 | Stratasys Inc (ISRAEL) | SSYS | 2 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $6.42 | $565,490,998.2 | Not reported | 0.67 |
| 191 | Neuronetics, Inc. Common Stock | STIM | 2 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $2.15 | $167,115,868.65 | Not reported | 7.46 |
| 192 | Stereotaxis, Inc. Common Stock | STXS | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.09 | $109,220,374.02 | Not reported | 6.25 |
| 193 | So-Young International Inc. American Depository Shares | SY | 2 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $2.05 | $190,823,553.38 | Not reported | 0.8 |
| 194 | TELA Bio, Inc. Common Stock | TELA | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.82 | $36,813,700.74 | Not reported | Not reported |
| 195 | Tempus AI, Inc. Class A Common Stock | TEM | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $76.05 | $13,338,483,040.35 | Not reported | 26.66 |
| 196 | Tandem Diabetes Care, Inc. | TNDM | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $16.91 | $1,180,213,935.86 | Not reported | 8.74 |
| 197 | Exagen Inc. Common Stock | XGN | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $5.81 | $140,749,219.59 | Not reported | 11.52 |
| 198 | DENTSPLY SIRONA Inc. | XRAY | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $9.46 | $1,874,533,793.88 | Not reported | 1.38 |
| 199 | ABVC BioPharma, Inc. Common Stock | ABVC | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.97 | $25,822,748.81 | Not reported | 2.1 |
| 200 | Accendra Health, Inc. | ACH | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.2 | $15,619,345.38 | Not reported | Not reported |
| 201 | Aclarion, Inc. Common Stock | ACON | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.66 | $4,784,734.2 | Not reported | 0.32 |
| 202 | Acrivon Therapeutics, Inc. Common Stock | ACRV | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.61 | $68,993,912.82 | Not reported | 0.8 |
| 203 | Allarity Therapeutics, Inc. Common Stock | ALLR | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.96 | $15,352,257.59 | Not reported | 4.34 |
| 204 | Autonomix Medical, Inc. Common Stock | AMIX | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.52 | $1,475,985.36 | Not reported | 0.47 |
| 205 | Bone Biologics Corp Common Stock | BBLG | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.33 | $1,129,911.6 | Not reported | 0.19 |
| 206 | BioCardia, Inc. Common Stock | BCDA | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.85 | $12,867,964.7 | Not reported | 4.77 |
| 207 | Biodesix, Inc. Common Stock | BDSX | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $8.53 | $94,584,998.83 | Not reported | 10.9 |
| 208 | Heartbeam, Inc. Common Stock | BEAT | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.4 | $22,652,366.74 | Not reported | 2.77 |
| 209 | Biofrontera Inc. Common Stock | BFRI | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.83 | $12,297,753.25 | Not reported | 2.06 |
| 210 | bioAffinity Technologies, Inc. Common Stock | BIAF | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.72 | $1,466,412.22 | Not reported | 0.39 |
| 211 | Bluejay Diagnostics, Inc. Common Stock | BJDX | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.35 | $1,165,414.35 | Not reported | 0.12 |
| 212 | BIOMERICA INC | BMRA | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.61 | $7,404,338.48 | Not reported | 2.03 |
| 213 | Burning Rock Biotech Limited American Depositary Shares | BNR | 1.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $13.42 | $874,860.54 | Not reported | 0.01 |
| 214 | Concord Medical Services Holding Limited | CCM | 1.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $3.71 | $16,107,791.71 | Not reported | 0.06 |
| 215 | Cardio Diagnostics Holdings Inc. Common stock | CDIO | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.65 | $4,886,083.32 | Not reported | 0.85 |
| 216 | Celularity Inc. Class A Common Stock | CELU | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.76 | $24,665,761.11 | Not reported | Not reported |
| 217 | Creative Medical Technology Holdings, Inc. Common Stock | CELZ | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.62 | $4,100,570.45 | Not reported | 0.47 |
| 218 | Canopy Growth Corporation Common Shares | CGC | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.65 | $275,814,263.2 | Not reported | 0.6 |
| 219 | CollPlant Biotechnologies Ltd Ordinary Shares | CLGN | 1.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $3.97 | $11,434,084.34 | Not reported | 1.88 |
| 220 | ClearPoint Neuro, Inc. Common Stock | CLPT | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $8.6 | $275,666,704.8 | Not reported | 10.11 |
| 221 | Co-Diagnostics, Inc. Common Stock | CODX | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.26 | $1,605,595.52 | Not reported | 0.13 |
| 222 | Cytosorbents Corp. | CTSO | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $4.8 | $15,082,257.6 | Not reported | Not reported |
| 223 | CapsoVision, Inc. Common Stock | CV | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $6.32 | $316,296,490.16 | Not reported | 24.02 |
| 224 | Dare Bioscience, Inc. Common Stock | DARE | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.64 | $9,769,991.78 | Not reported | Not reported |
| 225 | 3D Systems Corporation | DDD | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.75 | $291,115,154.75 | Not reported | 1.18 |
| 226 | Alpha Tau Medical Ltd. Ordinary Shares | DRTS | 1.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $13.72 | $1,268,800,272.88 | Not reported | 16.46 |
| 227 | Elutia Inc. Class A Common Stock | ELUT | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.84 | $37,087,801.2 | 0.72 | 2.36 |
| 228 | Evolus, Inc. Common Stock | EOLS | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $6.81 | $450,411,830.63 | Not reported | Not reported |
| 229 | Establishment Labs Holdings Inc. | ESTA | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $67.02 | $1,997,322,734.82 | Not reported | 92.44 |
| 230 | Femasys Inc. Common Stock | FEMY | 1.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $1.37 | $4,142,834.79 | Not reported | 1.03 |
| 231 | Fractyl Health, Inc. Common Stock | GUTS | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.93 | $12,333,784.91 | Not reported | Not reported |
| 232 | Vyome Holdings, Inc. Common Stock | HIND | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.58 | $11,089,274.24 | Not reported | 1.52 |
| 233 | Hyperion DeFi, Inc. Common Stock | HYPD | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.49 | $38,693,190.66 | 5.82 | 0.38 |
| 234 | Hyperfine, Inc. Class A Common Stock | HYPR | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.72 | $76,302,017.35 | Not reported | 2.08 |
| 235 | IceCure Medical Ltd. Ordinary Shares | ICCM | 1.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $0.68 | $3,157,345.95 | Not reported | 0.35 |
| 236 | SeaStar Medical Holding Corporation Common Stock | ICU | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.88 | $8,284,861.08 | Not reported | 1.93 |
| 237 | Insight Molecular Diagnostics Inc. Common Stock | IMDX | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.49 | $81,483,467.16 | Not reported | Not reported |
| 238 | Intelligent Bio Solutions Inc. Common Stock | INBS | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.97 | $5,964,115.9 | Not reported | 1.13 |
| 239 | Iridex Corp | IRIX | 1.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $0.66 | $11,547,173.15 | Not reported | 3.17 |
| 240 | INVO Fertility, Inc. Common Stock | IVF | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.14 | $1,341,227.88 | Not reported | 0.08 |
| 241 | Kairos Pharma, Ltd. | KAPA | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.49 | $1,651,728.37 | Not reported | Not reported |
| 242 | Standard BioTools Inc. Common Stock | LAB | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.64 | $251,086,720.48 | 1.89 | 0.45 |
| 243 | Lifeward Ltd. Ordinary Shares | LFWD | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $5.81 | $16,454,012.96 | Not reported | 1.35 |
| 244 | LENSAR, Inc. Common Stock | LNSR | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $5.45 | $66,957,964.25 | 1.93 | 2.33 |
| 245 | Lucid Diagnostics Inc. Common Stock | LUCD | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.4 | $80,891,100.06 | Not reported | 7.4 |
| 246 | Microbot Medical, Inc. Common Stock | MBOT | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.11 | $74,552,929.11 | Not reported | 1.08 |
| 247 | Medicus Pharma Ltd. Common Stock | MDCX | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.87 | $2,362,954.44 | Not reported | Not reported |
| 248 | MDxHealth SA Ordinary Shares | MDXH | 1.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $0.16 | $14,980,528.97 | Not reported | Not reported |
| 249 | Milestone Scientific, Inc. Common Stock | MLSS | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.3 | $26,799,233.87 | Not reported | 7.72 |
| 250 | Modular Medical, Inc. Common Stock | MODD | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.33 | $10,840,594.59 | Not reported | 1.01 |
| 251 | Nanobiotix S.A. American Depositary Shares | NBTX | 1.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $30.63 | $1,482,800,382.84 | Not reported | Not reported |
| 252 | NeuroOne Medical Technologies Corporation Common Stock | NMTC | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.88 | $8,003,965.68 | Not reported | 2.12 |
| 253 | NANO-X IMAGING LTD Ordinary Shares | NNOX | 1.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $0.24 | $18,915,031.32 | Not reported | 0.14 |
| 254 | Neuraxis, Inc. | NRXS | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $6.24 | $78,360,453.6 | Not reported | 11.63 |
| 255 | Nuwellis, Inc. Common Stock | NUWE | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $4.58 | $292,332.24 | Not reported | Not reported |
| 256 | enVVeno Medical Corporation Common Stock | NVNO | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $6.73 | $4,676,178.98 | Not reported | 0.28 |
| 257 | Nexalin Technology, Inc. Common Stock | NXL | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.47 | $1,079,784.09 | Not reported | 0.71 |
| 258 | Nyxoah SA Ordinary Shares | NYXH | 1.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $0.85 | $86,116,087.5 | Not reported | 1.49 |
| 259 | Orchestra BioMed Holdings, Inc. Ordinary Shares | OBIO | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $5.68 | $341,396,678.32 | Not reported | 11.6 |
| 260 | Outset Medical, Inc. Common Stock | OM | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $4.23 | $79,831,085.31 | Not reported | 0.96 |
| 261 | Onconetix, Inc. Common Stock | ONCO | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $6.95 | $2,744,631.45 | Not reported | 0.2 |
| 262 | PAVmed Inc. Common Stock | PAVM | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.57 | $12,559,188.4 | Not reported | 0.65 |
| 263 | Polyrizon Ltd. Ordinary Shares | PLRZ | 1.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $11.05 | $26,823,931.18 | Not reported | Not reported |
| 264 | Picard Medical, Inc. | PMI | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $9 | $21,047,706 | Not reported | 12.27 |
| 265 | Rani Therapeutics Holdings, Inc. Class A Common Stock | RANI | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.55 | $76,221,360.43 | Not reported | 1.59 |
| 266 | Avita Medical, Inc. Common Stock | RCEL | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $16.59 | $518,730,571.45 | Not reported | Not reported |
| 267 | TransCode Therapeutics, Inc. Common Stock | RNAZ | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.49 | $1,507,276.55 | Not reported | 0.01 |
| 268 | Retractable Technologies, Inc | RVP | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.57 | $16,926,469.7 | Not reported | 0.23 |
| 269 | Senseonics Holdings, Inc. Common Stock | SENS | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $8.59 | $454,188,115.27 | Not reported | 5.03 |
| 270 | Sera Prognostics, Inc. Class A Common Stock | SERA | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.19 | $86,394,330.54 | Not reported | 1.65 |
| 271 | Shuttle Pharmaceuticals Holdings, Inc. Common Stock | SHPH | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $5.59 | $5,591,506.53 | Not reported | 0.29 |
| 272 | SiNtx Technologies, Inc. Common Stock | SINT | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.56 | $11,790,855.96 | Not reported | 3.48 |
| 273 | SS Innovations International Inc. Common Stock | SSII | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.11 | $422,813,267.85 | Not reported | 7.92 |
| 274 | Streamex Corp. Common Stock | STEX | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.34 | $39,481,776.36 | Not reported | 0.27 |
| 275 | Talphera, Inc. Common Stock | TLPH | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.05 | $54,501,085.8 | Not reported | 3.78 |
| 276 | TriSalus Life Sciences, Inc. Common Stock | TLSI | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $3.25 | $200,117,450 | Not reported | 30.55 |
| 277 | Treace Medical Concepts, Inc. Common Stock | TMCI | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $4.03 | $264,205,175.91 | Not reported | 4.29 |
| 278 | Tenon Medical, Inc. Common Stock | TNON | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.64 | $15,494.72 | Not reported | Not reported |
| 279 | Universe Pharmaceuticals Inc. Class A Ordinary Shares | UPC | 1.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $1.39 | $783,039,820 | Not reported | 0.01 |
| 280 | Vivani Medical, Inc. Common Stock (DE) | VANI | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.07 | $96,517,590.92 | Not reported | 5.09 |
| 281 | INNOVATE Corp. | VATE | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $5.26 | $71,756,215.16 | Not reported | Not reported |
| 282 | VolitionRx Limited | VNRX | 1.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $0.2 | $2,673,914.33 | Not reported | Not reported |
| 283 | Virax Biolabs Group Limited Ordinary Shares | VRAX | 1.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $0.79 | $1,065,096 | Not reported | 0.15 |
| 284 | Vivos Therapeutics, Inc. Common Stock | VVOS | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.09 | $1,885,058.76 | Not reported | Not reported |
| 285 | WORK Medical Technology Group LTD Class A Ordinary Shares | WOK | 1.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $0.95 | $4,223,648.24 | Not reported | 0.2 |
| 286 | Beyond Air, Inc. Common Stock | XAIR | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.16 | $2,068,482.96 | Not reported | 0.73 |
| 287 | Zepp Health Corporation American depositary shares, each representing sixteen Class A ordinary shares | ZEPP | 1.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $2.25 | $33,030,844.17 | Not reported | 0.15 |
| 288 | Adagio Medical Holdings, Inc Common Stock | ADGM | 1 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.06 | $1,441,458.79 | Not reported | Not reported |
| 289 | Advanced Biomed Inc. Common Stock | ADVB | 1 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.98 | $3,271,223.34 | 0.49 | 0.27 |
| 290 | Firefly Neuroscience, Inc. Common Stock | AIFF | 1 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.91 | $14,281,325.62 | Not reported | 0.97 |
| 291 | Ainos, Inc. Common Stock | AIMD | 1 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.7 | $5,154,082.95 | Not reported | 1.57 |
| 292 | Anteris Technologies Global Corp. Common Stock | AVR | 1 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $5.69 | $554,538,717.06 | Not reported | 2.2 |
| 293 | Envoy Medical, Inc. Class A Common Stock | COCH | 1 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $7.15 | $55,373,089.2 | Not reported | Not reported |
| 294 | Cuprina Holdings (Cayman) Limited Class A Ordinary Shares | CUPR | 1 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $1.8 | $12,606,764.4 | Not reported | 3.21 |
| 295 | HeartSciences Inc. Common Stock | HSCS | 1 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.83 | $13,584,486.76 | Not reported | Not reported |
| 296 | Solana Company Class A Common Stock (DE) | HSDT | 1 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.93 | $116,685,296.79 | Not reported | 0.69 |
| 297 | Corvex, Inc. Common Stock | MOVE | 1 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $5.01 | $10,321,526.85 | Not reported | 0.02 |
| 298 | ENDRA Life Sciences Inc. Common Stock | NDRA | 1 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $4.73 | $7,094,233.74 | Not reported | 1.12 |
| 299 | Oragenics Inc. | OGEN | 1 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.35 | $1,575,349.79 | Not reported | 0.43 |
| 300 | Profusa, Inc. Common Stock | PFSA | 1 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.53 | $706.88 | Not reported | Not reported |
| 301 | Turn Therapeutics Inc. Common Stock | TTRX | 1 | 2026-10-14 | 2026 IPO | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $9.48 | $282,390,619.2 | Not reported | 411.12 |
No matching rows. Clear the filter to see all records.
301 companies with eligible ratings and dated fundamentals, from 309 eligible companies in this selection.
Inspect the highest-rated company
Ratings and dated fundamentals
Medical Devices: source evidence dated 2026-11-07T12:42:51.530Z.
- Rank
- 1
- Company
- ResMed Inc.
- Ticker
- RMD
- Rating / 5
- 4.5
- Report date
- 2025-12-31
- Fiscal period
- 2025 FY
- Model
- anthropic/claude-haiku-5-5
- Market day
- 2026-11-06
The selected ticker, rating, report date and producing model match the first displayed row. Equal ratings use ticker order.
Which company leads this published industry selection?
The first row is highest by the stored 1-to-5 report rating, not forecast return. Check its report date, fiscal period and model.
NexusTrade stock ratings and report filters- Median market capitalization
- $450,411,830.63 · 301 / 301 displayed companies
- Median positive P/E (TTM)
- 28.68 · 112 / 301 displayed companies
- Median positive price / book
- 2.37 · 251 / 301 displayed companies
- Largest company by market cap
- Berkshire Hathaway Inc. (BRK-A) · $1,222,245,324,463.29
- Largest company's share of displayed market cap
- 18.39% · Sum of displayed market caps; not portfolio weights or revenue exposure
Check each median’s included count and each company’s market date. These are unweighted summaries of displayed companies, not a sector index or revenue exposure.
Open this industry in the stock screener
Read the company's fundamentals and compare another dated report before treating equal ratings as equal businesses.
Open this industry in the stock screenerKeep reporting dates and units beside the answer, and inspect its original citations.
How is this ranking built?

Every industry list applies the same steps at its own cutoff: industry membership, the latest AI report rating on or before the cutoff, a report age limit, dated market data, then a sort by rating with ties ordered by ticker. The animation steps through them with one real example, the live cybersecurity list refreshed on October 13, 2026.
A live list's cutoff is its refresh time. A past year's list uses December 31 of the year before, and the current year's list uses the time it was generated. A Top N page shows the first N rows of its year's list and exists only when that list has at least N companies.
What best means in this list
This list was refreshed on 2026-11-07 using existing company reports. The report date in each row is the date of the underlying analysis; refreshing the list does not create a new company report.
Best means the highest stored NexusTrade report ratings within this selection. Ratings use the product's 1-to-5 scale. The list sorts by rating from high to low, with ticker order breaking equal-rating ties. A rating summarizes a report; it does not predict a stock's return.
Companies belong to the Medical Devices classification, based on company products and revenue. Classifications can overlap, so a company may appear in several industry lists.
What the leading companies do
The first 5 companies below lead the ratings in this snapshot; equal ratings are ordered by ticker. Their company profiles describe different businesses even when they share the Medical Devices selection.
These are company descriptions, not estimates of revenue from this theme. Industry membership does not identify a pure-play business or establish how much sales depend on it. Open the company profile and examine segment disclosures before treating an overlapping classification as equivalent exposure.
ResMed Inc. (RMD): 4.5 / 5
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Ametek, Inc. (AME): 4 / 5
AMETEK, Inc. manufactures and sells electronic instruments (EIG) and electromechanical (EMG) devices in the United States and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and metering devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and gas turbines sensors; dashboard instruments for heavy trucks and other vehicles; instrumentation and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry. Its EMG segment offers engineered medical components and devices, automation solutions, thermal management systems, specialty metals, and electrical interconnects; single-use and consumable surgical instruments, implantable components, and drug delivery systems; engineered electrical connectors and electronics packaging to protect sensitive electronic devices; precision motion control products for data storage, medical devices, business equipment, and automation; high-purity powdered metals, strips and foils, specialty clad metals, and metal matrix composites; motor-blower systems and heat exchangers for thermal management, military and commercial aircraft, and military ground vehicles; and motors for commercial appliances, food and beverage machines, hydraulic pumps, and industrial blowers, as well as operates a network of aviation maintenance, repair, and overhaul facilities. AMETEK, Inc. was incorporated in 1930 and is headquartered in Berwyn, Pennsylvania.
Idexx Laboratories Inc (IDXX): 4 / 5
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, it offers diagnostic tests, services, and related instrumentation for manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
iRadimed Corporation (IRMD): 4 / 5
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. The company offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. The company was incorporated in 1992 and is headquartered in Winter Springs, Florida.
Intuitive Surgical Inc. (ISRG): 4 / 5
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.
Valuation and company size within this selection
These summaries use the 301 displayed companies. Each company retains its own market observation date in the ratings table above. Medians are unweighted; they are not a sector index valuation.
Positive P/E and price-to-book values are summarized separately. Missing, zero and negative values are excluded from those medians, with the included count shown. A lower multiple alone does not establish better value: profitability, growth, debt and business mix can differ.
Show the table · 5 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Median market capitalization | $450,411,830.63 | 301 / 301 displayed companies |
| Median positive P/E (TTM) | 28.68 | 112 / 301 displayed companies |
| Median positive price / book | 2.37 | 251 / 301 displayed companies |
| Largest company by market cap | Berkshire Hathaway Inc. (BRK-A) | $1,222,245,324,463.29 |
| Largest company's share of displayed market cap | 18.39% | Sum of displayed market caps; not portfolio weights or revenue exposure |
No matching rows. Clear the filter to see all records.
Other business classifications in the list
A company can appear in several product and revenue classifications. These overlapping memberships help identify different business mixes to investigate; they are not verified revenue shares or mutually exclusive subindustries.
Show the table · 5 rows, 2 columns
| Additional classification | Matching displayed companies |
|---|---|
| Healthcare | 300 / 301 |
| Manufacturing | 206 / 301 |
| Technology | 201 / 301 |
| Hardware | 187 / 301 |
| Pharmaceuticals | 73 / 301 |
No matching rows. Clear the filter to see all records.
Dates and coverage
Report dates range from 2025-12-31 to 2026-10-14. Market observations range from 2026-11-06 to 2026-11-06. These dates may differ across companies. Daily closes are not synchronized live quotes.
The selection includes 4 companies without a report, 0 with invalid latest rating metadata, 1 with older reports, 3 with missing required fundamentals and 0 with out-of-date market observations. Missing companies receive no substitute score.
How the ranking is built
The ranking uses the latest stored report at or before the refresh cutoff for each active eligible company. The report date, fiscal year/period and producing model remain visible. The latest invalid score is excluded; an older favorable score does not replace it. Publication policy stock-ratings-v1 accepts report ages up to 550 days and market observations up to 10 calendar days, with a positive close and market capitalization. Optional missing ratios remain not reported.
Report ages can differ substantially, particularly between annual and quarterly reports. Different producing models may also use different judgments. Read the date, fiscal period and model before comparing scores. Private report analysis and account data are not published here.
A refresh reads existing reports and market data. It does not rerun a model or create a new analysis. Compare business fundamentals and your own research constraints alongside the score before making a decision.